The company established a new protocol for the study and will advance its drug response predictor as a companion diagnostic.

The transaction was approved by both companies' boards and includes a significant premium over recent stock prices for ...

We are excited to welcome the talented team at Regulus to Novartis as we continue to build on our pipeline in renal disease with high unmet medical need.” Farabursen is an investigational ...

Viking Therapeutics: Evaluating Pipeline Maturity, And Takeover Potential Jun. 02, 2025 10:51 AM ET Altimmune, Inc. (ALT) Stock , VKTX Stock PFE , PFE:CA , ALT , VKTX 74 Comments BioCGT Investor ...

The company has shown its revolutionary technology can deliver life-changing therapies. Now, it's about whether CRISPR Therapeutics can replicate the success across its promising pipeline.

Odylia Therapeutics, a nonprofit (501(c)3) biotechnology company dedicated to advancing treatments for rare diseases, today announced its latest pipeline project: a unique and innovative co ...

Mosaic Therapeutics a UK-based oncology company has announced it has in-licensed two clinical-stage oncology programmes from Astex Pharmaceuticals. The agreement transforms Mosaic from a ...

CRISPR Therapeutics (CRSP-2.01%) is a biotech that generally tackles specialties different from those of Vertex, though it has partnered with Vertex on certain programs.

Endlyz Therapeutics has launched from stealth, unveiling its pipeline of small molecule modulators designed to restore lysosomal function in Parkinson’s disease (PD) and other neurodegenerative ...

Apogee Therapeutics. Accelerated execution of Phase 2 APEX clinical trial for APG777, with Part A over-enrolled and Part B initiated ahead of schedule; topline Part A 16-week data expected mid-2025 ...

On Thursday, HC Wainwright downgraded LAVA Therapeutics to Neutral from Buy with a price target of $1.50, citing pipeline overhang despite substantial cash reserve.